This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers, clinicians and innovators. The series will help attendees anticipate, access, and apply new approaches and technologies for patient care.
Genetic Test Interpretation from Pathogenicity to Variant Function
Dr. Las will present approaches to interpret clinical genetic tests of patients with neurodevelopmental disorders and epilepsy, while considering variant pathogenicity and function.
Objectives:
- Identify the current status of genetics in neurodevelopmental disorders.
- Assess the use of genetic testing.
- Consider patient selection for precision medicine trials.
Speaker – Dr. Dennis Lal
Bio
The Lal Research Group focuses on the discovery, evaluation, and translation of biomarker into clinical care. Specifically, we aim to develop computational methods which integrate large genetic, clinical, and biological data sets to improve the prediction of patient outcomes – paving the way for personalized medicine.
Dennis is Assistant Professor in the Department of Molecular Medicine in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (CCLCM) and Assistant Staff in the Genomic Medicine Institute with a secondary staff appointment in the Neurological Institute’s Epilepsy Center both Cleveland, US. In addition to his primary appointments in Cleveland, he is Visiting Scientist at the Broad Institute of Harvard and M.I.T., Cambridge, US as well as Group Leader at the Cologne Center for Genomics, Cologne, Germany.
Dates
September 23
October 28
November 25
December 16
January 27
February 24
March 31
April 28
May 26
June 30
Click HERE to register.
